InsidersTradesSigma
Track the China Pharma Holdings, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, China Pharma Holdings, INC. has recorded 2 insider filings. Market capitalisation: €328.2m. The latest transaction was disclosed on 19 October 2023 (Attribution). Among the most active insiders: Li Zhilin. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,255 of 29,065 companies
17.4
score / 100
Value29
Quality6
FCF yld0.0%
Earn yld-7.2%
EV/EBITDA·
ROE-16%
Gross mgn-3.2%
Net mgn-77%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 October 2023
关于 China Pharma Holdings, INC.
China Pharma Holdings, INC. 是一家专注于健康和制药领域的公司。它在纳斯达克上市，股票代码为XNAS。
